| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Stifel senkt Kursziel für Outset Medical auf 8 US-Dollar, behält aber Kaufempfehlung bei | 3 | Investing.com Deutsch | ||
| Mi | Stifel lowers Outset Medical stock price target to $8 from $14 | 1 | Investing.com | ||
| 16.12.25 | BTIG reiterates Buy rating on Outset Medical stock, maintains $17 target | 10 | Investing.com | ||
| OUTSET MEDICAL Aktie jetzt für 0€ handeln | |||||
| 12.11.25 | Outset Medical auf der Stifel-Konferenz 2025: Zwischen Herausforderungen und strategischer Neuausrichtung | 12 | Investing.com Deutsch | ||
| 11.11.25 | Outset Medical Shares Sink 47% After Q3 Miss And Lowered Full-Year Outlook | 11 | RTTNews | ||
| 11.11.25 | Outset Medical stock is down on Q3 misses, slashed guidance | 8 | MassDevice | ||
| 11.11.25 | Stifel senkt Kursziel für Outset Medical von 17 auf 14 US-Dollar | 4 | Investing.com Deutsch | ||
| 11.11.25 | Outset Medical stock price target lowered to $14 from $17 at Stifel | 6 | Investing.com | ||
| 11.11.25 | Outset Medical stock falls as BTIG lowers price target to $17 from $19 | 1 | Investing.com | ||
| 11.11.25 | Sea, Outset Medical And 3 Stocks To Watch Heading Into Tuesday | 2 | Benzinga.com | ||
| 11.11.25 | Outset Medical signals $115M-$120M revenue guidance revision amid sales process transformation and leadership change | 5 | Seeking Alpha | ||
| 10.11.25 | Earnings Call Transkript: Outset Medical meldet Umsatzwachstum für Q3 2025 | - | Investing.com Deutsch | ||
| 10.11.25 | Outset Medical, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 10.11.25 | Outset Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 05.11.25 | Outset Medical, Inc.: New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical's Tablo Hemodialysis System | 2 | GlobeNewswire (USA) | ||
| 27.10.25 | Outset Medical, Inc.: Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025 | 5 | GlobeNewswire (USA) | ||
| 29.09.25 | Outset Medical: Stifel bestätigt "Buy"-Rating und Kursziel von 17 US-Dollar | 3 | Investing.com Deutsch | ||
| 29.09.25 | Stifel reaffirms Buy rating on Outset Medical stock at $17 price target | 1 | Investing.com | ||
| 03.09.25 | Outset Medical, Inc.: Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis | 1 | GlobeNewswire (USA) | ||
| 07.08.25 | Pre-market Movers: Montrose Environmental Group, Outset Medical, Redwire, Duolingo, Tutor Perini | 691 | AFX News | WASHINGTON (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.15 A.M. ET).In the Green Montrose Environmental Group, Inc. (MEG) is up... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,750 | +1,59 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,010 | -0,43 % | EILMELDUNG: Fresenius Medical Care-Aktie bricht ein - Panik greift um sich! | ||
| CARL ZEISS MEDITEC | 41,680 | -2,25 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,410 | -2,41 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| UNITEDHEALTH | 297,70 | +1,73 % | Aktien New York: Dow steuert mit Rekord auf 50.000 Punkte zu | NEW YORK (dpa-AFX) - Die Jahresauftakt-Rally an den US-Börsen ist am Dienstag weitergegangen. Der Leitindex Dow Jones Industrial stieg den zweiten Handelstag in Folge auf ein Rekordhoch und steuert... ► Artikel lesen | |
| DRAEGERWERK | 73,90 | +1,09 % | DRAEGERWERK AG & CO KGAA ST zeigt strukturelle Stärke | ||
| MEDTRONIC | 85,28 | -0,15 % | Medtronic Benefits Are Built for Every Chapter | Employees feel confident in their future, cared for in the present, and supported through life's biggest moments. NORTHAMPTON, MA / ACCESS Newswire / January 5, 2026 / As a global leader in healthcare... ► Artikel lesen | |
| INTUITIVE SURGICAL | 502,40 | -0,97 % | Is ISRG Stock Still A Buy At $600? | ||
| THERMO FISHER | 520,10 | -1,55 % | Dividendenbekanntmachungen (15.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2969 EUR AMERICAN HOMES 4 RENT US02665T3068 0,3 USD 0,2555 EUR ARES CAPITAL... ► Artikel lesen | |
| TELADOC HEALTH | 6,496 | +0,15 % | BofA Securities lowers Teladoc stock price target to $7.50 on segment uncertainties | ||
| ESSILORLUXOTTICA | 275,50 | +1,10 % | UBS stuft EssilorLuxottica auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für EssilorLuxottica auf "Buy" mit einem Kursziel von 352 Euro belassen. Zuzanna Pusz rechnet in einer am Montag vorliegenden... ► Artikel lesen | |
| ROKU | 93,70 | -0,75 % | Evercore ISI upgrades Roku stock rating to Outperform on 2026 catalysts | ||
| HIMS & HERS HEALTH | 28,860 | -4,97 % | GraniteShares YieldBOOST HIMS ETF declares $0.496 dividend | ||
| EUROFINS SCIENTIFIC | 69,20 | -0,37 % | Eurofins Scientific SE: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,530 | +0,48 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen |